HCV Eradication With New IFN Free Treatment Improves Metabolic Profile in HCV-related Liver Transplant Recipients

Liver Transplantation - United States
doi 10.1002/lt.25060
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Donor Diabetes Mellitus Is an Independent Risk Factor for Graft Loss in HCV Positive but Not HCV Negative Liver Transplant Recipients

Digestive Diseases and Sciences
PhysiologyGastroenterology
2012English

Editorial: Benefits of HCV Eradication Beyond the Liver

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2019English

A Prospective Study of Daclatasvir and Sofosbuvir in Chronic HCV-infected Kidney Transplant Recipients

BMC Nephrology
Nephrology
2019English

MicroRNA Profile of HCV Spontaneous Clarified Individuals, Denotes Previous HCV Infection

Journal of Clinical Medicine
2019English

Liver Fibrosis Progression Despite HCV Cure With Antiviral Therapy in HIV–HCV-coinfected Patients

Antiviral Therapy
Infectious DiseasesPharmacology
2014English

HCV/HIV Coinfection: A New Treatment Paradigm

Gastroenterology
HepatologyGastroenterology
2015English

Immunomodulating Effects of the Anti-Viral Agent Silibinin in Liver Transplant Patients With HCV Recurrence

Transplantation Research
TransplantationImmunology
2016English

Metabolic Syndrome in Liver Transplant Recipients: Prevalence and Association With Major Vascular Events

Liver Transplantation
HepatologyTransplantationSurgery
2007English

Lymphocytes as Liver Damage Mirror of HCV Related Adipogenesis Deregulation

PLoS ONE
Multidisciplinary
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy